220 related articles for article (PubMed ID: 20616584)
1. Advances of imaging for hepatocellular carcinoma.
Choi BI
Oncology; 2010 Jul; 78 Suppl 1():46-52. PubMed ID: 20616584
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular nodules in liver cirrhosis: MR evaluation.
Lee JM; Choi BI
Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
[TBL] [Abstract][Full Text] [Related]
3. The current status of imaging diagnosis of hepatocellular carcinoma.
Choi BI
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S20-5. PubMed ID: 14762834
[TBL] [Abstract][Full Text] [Related]
4. Radiologic diagnosis of hepatocellular carcinoma.
Ishiguchi T; Shimamoto K; Fukatsu H; Yamakawa K; Ishigaki T
Semin Surg Oncol; 1996; 12(3):164-9. PubMed ID: 8727605
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of hepatocellular carcinoma: newer radiological tools.
Lee JM; Yoon JH; Kim KW
Semin Oncol; 2012 Aug; 39(4):399-409. PubMed ID: 22846858
[TBL] [Abstract][Full Text] [Related]
6. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
7. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
8. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
9. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
10. The role of imaging in hepatocellular carcinoma: the present and future.
Davarpanah AH; Weinreb JC
J Clin Gastroenterol; 2013 Jul; 47 Suppl():S7-10. PubMed ID: 23632342
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation.
Kim SH; Choi BI; Lee JY; Kim SJ; So YH; Eun HW; Lee JM; Han JK
Intervirology; 2008; 51 Suppl 1():52-60. PubMed ID: 18544949
[TBL] [Abstract][Full Text] [Related]
12. CT and MRI of hepatocellular carcinoma: an update.
Ayyappan AP; Jhaveri KS
Expert Rev Anticancer Ther; 2010 Apr; 10(4):507-19. PubMed ID: 20397916
[TBL] [Abstract][Full Text] [Related]
13. [Integrated diagnosis of small hepatocellular carcinoma with imaging diagnosis].
Sekoguchi B; Horiguchi Y; Imai H; Suzuki T; Miyoshi A; Itoh H; Kubo H; Itoh M
Rinsho Byori; 1994 Oct; 42(10):1036-42. PubMed ID: 7996712
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of hepatocellular carcinoma.
Kanematsu M; Kondo H; Goshima S; Tsuge Y; Watanabe H
Oncology; 2008; 75 Suppl 1():65-71. PubMed ID: 19092274
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic imaging and interventional therapy in hepatocarcinoma. Multicenter study of 290 cases].
Dalla Palma L; Pozzi Mucelli R; Sponza M; Bartolozzi C; Lencioni R; Florio F; De Santis M; Gandini G; Matricardi L; Rossi C; Simonetti G; Pocek M
Radiol Med; 1997; 94(1-2):30-6. PubMed ID: 9424647
[TBL] [Abstract][Full Text] [Related]
17. Imaging of HCC.
Ayuso C; Rimola J; García-Criado A
Abdom Imaging; 2012 Apr; 37(2):215-30. PubMed ID: 21909721
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
Ito K
Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
[TBL] [Abstract][Full Text] [Related]
19. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
Kudo M
Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
